<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68657">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01694940</url>
  </required_header>
  <id_info>
    <org_study_id>AAAF4597</org_study_id>
    <nct_id>NCT01694940</nct_id>
  </id_info>
  <brief_title>North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)</brief_title>
  <acronym>NAMDC</acronym>
  <official_title>North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The North American Mitochondrial Disease Consortium (NAMDC)maintains a patient contact
      registry and tissue biorepository for patients with mitochondrial disorders.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mitochondrial diseases comprise a group of relatively rare (~1 in 5000 adults) but very
      serious genetic disorders. Mitochondria are often called the &quot;powerhouses of the cell&quot;
      because they provide the energy our cells need to live. Mitochondria have their own DNA
      (mtDNA), but they also rely on DNA from the nucleus (nDNA). Mitochondrial diseases are
      caused by mutations in either mitochondrial or nuclear DNA that result in poorly functioning
      mitochondria. This can cause a variety of symptoms including muscle weakness, seizures,
      mental retardation, dementia, hearing loss, blindness, strokes, diabetes, and premature
      death. Most mitochondrial diseases are progressive, and we are unable to cure most of these
      diseases with currently available treatments.

      Research into mitochondrial diseases has been hampered by the low frequency of these
      disorders and by under-diagnosis by clinicians. This has hindered patient recruitment for
      research studies and clinical trials. The North American Mitochondrial Disease Consortium
      (NAMDC) was established to help surmount these issues. Led jointly by Drs. Michio Hirano and
      Salvatore DiMauro, NAMDC is a consortium of several clinicians and researchers with an
      interest in mitochondrial disease research in the United States and Canada.

      By creating a mechanism for the sharing of patient samples with researchers, data and
      patient contact information, NAMDC will make it easier to conduct clinical and basic
      laboratory research.

      Patient information will be shared through the use of the &quot;Patient Data Registry,&quot; a
      specially-designed database, and patient tissue samples will be shared through the use of
      the &quot;Patient Sample Biorepository&quot;, a storage facility in which patient-derived biological
      samples will be maintained. The Registry and the Biorepository will hopefully accelerate
      progress in the understanding and treatment of mitochondrial disease.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>There is no primary outcome measure for this study</measure>
    <time_frame>end of study</time_frame>
    <safety_issue>No</safety_issue>
    <description>This is a registry protocol and therefore there is no primary outcome measure for this study.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Mitochondrial Disorders</condition>
  <condition>Mitochondrial Genetic Disorders</condition>
  <condition>Mitochondrial Diseases</condition>
  <condition>Disorder of Mitochondrial Respiratory Chain Complexes</condition>
  <condition>Deletion and Duplication of Mitochondrial DNA</condition>
  <arm_group>
    <arm_group_label>Mitochondrial Disease Patients</arm_group_label>
    <description>Patients with possible or known mitochondrial disorders. Patients who are known carriers of mitochondrial or nuclear DNA mutations involved in mitochondrial function.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Any type of tissue sample can be stored in the biorepository.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with known mitochondrial disorders. People at risk of carrying a mitochondrial
        DNA mutation Patients with abnormal mitochondrial function
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with or suspected to have a mitochondrial disorder

          -  Adult carriers of known mitochondrial DNA mutations

          -  Patients with laboratory analysis indicative of a mitochondrial disorder.

          -  Medical information and tissue samples are also accepted from deceased individuals
             who fulfill the above criteria.

        Exclusion Criteria:

          -  Patients not suspected of having a mitochondrial disorder

          -  Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that
             affects mitochondrial function.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michio Hirano, MD</last_name>
    <role>Study Director</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michio Hirano, MD</last_name>
    <phone>12123051048</phone>
    <email>NAMDC@columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Johnston Grier</last_name>
    <phone>12123423671</phone>
    <email>NAMDC@columbia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Hass, MD</last_name>
      <phone>858-822-6700</phone>
      <email>rhass@ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Robert Naviaux, MD</last_name>
      <phone>16195432904</phone>
      <email>naviaux@ucsd.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Naviaux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Haas, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lucile Packard Children's Hospital</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Enns, MD</last_name>
      <phone>650-723-6858</phone>
    </contact>
    <investigator>
      <last_name>Gregory Enns, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johan Van Hove, MD PhD MBA</last_name>
      <phone>303-724-2351</phone>
    </contact>
    <contact_backup>
      <last_name>Abigail Collins, MD</last_name>
      <phone>7207776895</phone>
      <email>abibail.collins@ucdenver.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Johan Van Hove, MD PhD MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Abigail Collins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington DC</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Gropman, MD</last_name>
      <phone>202-476-3511</phone>
      <email>agropman@cnmc.org</email>
    </contact>
    <investigator>
      <last_name>Andrea Gropman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainsville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Stacpole, MD</last_name>
      <phone>352-265-8909</phone>
      <email>stacpool@gcrc.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Stacpole, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amel Karaa, MD</last_name>
      <phone>617-355-6117</phone>
      <email>akaraa@partners.org</email>
    </contact>
    <contact_backup>
      <last_name>Katherine Sims, MD</last_name>
      <phone>6177265732</phone>
      <email>ksims@partners.org</email>
    </contact_backup>
    <investigator>
      <last_name>Amel Karaa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katherine Sims, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralitza Garivolova, MD</last_name>
      <phone>507-284-2511</phone>
      <email>gavrilova.ralitza@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Ralitza Gavrilova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Buffalo General Hospital</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgirene VLadutiu, PhD</last_name>
      <phone>716-859-7741</phone>
      <email>gdv@buffalo.edu</email>
    </contact>
    <investigator>
      <last_name>Georgirene Vladutiu, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michio Hirano, MD</last_name>
      <phone>212-305-1048</phone>
      <email>namdc@columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Salvatore DiMauro, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Michio Hirano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Salvatore Dimauro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Akron Children's Hospital</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Cohen, MD</last_name>
      <phone>330-543-6048</phone>
      <email>bcohen@chmca.org</email>
    </contact>
    <investigator>
      <last_name>Bruce Cohen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University</name>
      <address>
        <city>Clevland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Hoppel, MD</last_name>
      <phone>216-368-3147</phone>
      <email>charles.hoppel@case.edu</email>
    </contact>
    <contact_backup>
      <last_name>Douglas Kerr, MD</last_name>
      <phone>12168443661</phone>
      <email>douglas.kerr@case.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Charles Hoppel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Douglas Kerr, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clevland Clinic</name>
      <address>
        <city>Clevland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sumit Parikh, MD</last_name>
      <phone>216-444-1994</phone>
      <email>parikhs@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Sumit Parikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marni J Falk, MD</last_name>
      <phone>215-590-4564</phone>
      <email>falkm@email.chop.edu</email>
    </contact>
    <investigator>
      <last_name>Marni J Falk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Goldstein, MD</last_name>
      <phone>412-692-5520</phone>
    </contact>
    <investigator>
      <last_name>Amy Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical School</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Haller, MD</last_name>
      <phone>214-345-4617</phone>
      <email>rhaller2@earthlink.net</email>
    </contact>
    <contact_backup>
      <last_name>Juan Pascual, MD PhD</last_name>
      <phone>12146485818</phone>
      <email>juan.pascual@UTsouthwestern.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ronald Haller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Pascual, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Craigen, MD</last_name>
      <phone>713-798-8305</phone>
      <email>wcraigen@bcm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Fernando Scaglia, MD</last_name>
      <phone>18328224280</phone>
      <email>fscaglia@bcm.tmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>William Craigen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernando Scaglia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital and Regional Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Russell Saneto, MD</last_name>
      <phone>206-987-2100</phone>
      <phone_ext>4017</phone_ext>
      <email>russ.saneto@seattlechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Russell Saneto, DO PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>ON L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Tarnopolsky, MD</last_name>
      <phone>19055212100</phone>
      <phone_ext>75226</phone_ext>
      <email>tarnopol@univmail.cis.mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>Mark Tarnopolsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://rarediseasesnetwork.epi.usf.edu/NAMDC/</url>
    <description>Rare Disease Clinical Research Network NAMDC Home Page</description>
  </link>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 18, 2013</lastchanged_date>
  <firstreceived_date>September 25, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Michio Hirano</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <keyword>mitochondrial disorders</keyword>
  <keyword>Mito Disease</keyword>
  <keyword>Mitochondria</keyword>
  <keyword>Mitochondrial disease</keyword>
  <keyword>MELAS</keyword>
  <keyword>MERRF</keyword>
  <keyword>LHON</keyword>
  <keyword>Leigh Syndrome</keyword>
  <keyword>Leighs</keyword>
  <keyword>NARP</keyword>
  <keyword>Kearns Sayer</keyword>
  <keyword>CPEO</keyword>
  <keyword>Alpers</keyword>
  <keyword>Pearson</keyword>
  <keyword>MEMSA</keyword>
  <keyword>Barth Syndrome</keyword>
  <keyword>CoQ Deficiency</keyword>
  <keyword>DAD</keyword>
  <keyword>Diabetes and Deafness</keyword>
  <keyword>Encephalopathy</keyword>
  <keyword>Encephalomyopathy</keyword>
  <keyword>FBSN</keyword>
  <keyword>Hepatocerebral Disease</keyword>
  <keyword>Leukoencephalopathy</keyword>
  <keyword>MILS</keyword>
  <keyword>Complex I Deficiency</keyword>
  <keyword>Complex II Deficiency</keyword>
  <keyword>Complex III Deficiency</keyword>
  <keyword>Complex IV Deficiency</keyword>
  <keyword>Complex V Deficiency</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Genetic Diseases, Inborn</mesh_term>
    <mesh_term>Mitochondrial Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
